Astronics ((ATRO)) has held its Q4 earnings call. Read on for the main highlights of the call.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Astronics’ latest earnings call struck an upbeat tone as management detailed a record quarter across revenue, margins, and cash generation. Executives acknowledged a few near‑term pressures, including higher net debt, tariff uncertainty, and heavier capital and ERP spending, but emphasized that these are largely timing‑related against a backdrop of robust demand and record backlog.
Record Revenue Sets New Benchmark
Astronics reported fourth‑quarter revenue of $240 million, setting a new company record and surpassing its prior high from 2018 by almost 13%. Sales rose 15.1% year over year and 13.5% sequentially, underscoring broad demand strength across its end markets.
Gross Margin Expands Sharply
Gross profit jumped nearly 29% in the quarter to $80 million, outpacing the revenue growth. Gross margin expanded 350 basis points year over year to 33.3%, reflecting better pricing, improved mix, and ongoing cost‑reduction efforts.
Operating Income and EBITDA Hit Post‑Pandemic Highs
Operating income reached $35.5 million in the quarter, translating to a 14.8% operating margin that marks a post‑pandemic high for the company. Adjusted EBITDA margin climbed to 19%, signaling that Astronics is converting a larger portion of its sales into profits.
Aerospace Segment Drives Profit Surge
The Aerospace segment delivered operating profit of $41.7 million, roughly 2.5 times the prior‑year level, making it the main earnings engine. Aerospace operating margin approached 19%, while adjusted margin of about 19.8% reflected roughly 380 basis points of expansion versus a year ago.
Full‑Year Profitability Metrics Improve
For the full year, Astronics’ adjusted operating margin improved to 12.2% from 7.7% in the prior period, with adjusted EBITDA margin advancing to 15.6% from 12.1%. Revenue for the year grew 8.4%, indicating that profitability gains came both from volume and from better efficiency.
Cash Generation, Liquidity and Backlog Underpin Growth
The company generated $27.6 million of cash from operations in the fourth quarter and $74.8 million for the full year, adding flexibility to the balance sheet. Astronics ended the year with $231 million of available liquidity and a record backlog of $674.5 million, supported by Q4 bookings of $257 million and a book‑to‑bill ratio of 1.07.
Lower Litigation Costs Support Leverage
Selling, general and administrative expense fell by $7.3 million in the quarter, largely due to a $9 million reduction in legal reserves and litigation‑related costs. This drop in overhead helped drive stronger operating leverage, allowing more revenue growth to pass through to earnings.
Test Systems Returns to Profitability
The Test Systems segment produced an operating profit of $1.1 million in the quarter, reversing a slightly negative result a year earlier. Management attributed the improvement to restructuring and simplification measures, though they cautioned that further gains depend on volume ramps.
Pricing Actions Near Completion
Executives reported that repricing initiatives are roughly 70% to 80% complete as the company responds to prior inflationary cost pressures. These pricing gains have played a key role in restoring margins and are expected to continue supporting profitability as remaining contracts are updated.
Net Debt Climbs After Refinancing Moves
Net debt rose sharply to $324.8 million at year‑end from $156.6 million the prior year, primarily due to refinancing steps and the repurchase of about 80% of the company’s 5.5% convertible bonds at a cost of roughly $285.8 million. Management framed these actions as positioning the balance sheet for long‑term flexibility despite the near‑term leverage increase.
Tariff Costs and Legal Overhang Persist
Astronics incurred $2.9 million in higher tariff expenses during the quarter and faces ongoing uncertainty following a recent court ruling. Roughly $8 million of previously paid incremental tariffs remain under review, and the company has assumed no benefit from potential recovery in its current outlook.
CapEx and ERP Spending to Pressure Cash Flow
The company plans 2026 capital expenditures of $40 million to $50 million, alongside $14 million to $18 million in ERP program spending that will flow through operating cash. The ERP rollout is expected to last about five years, with the heaviest cash burden in 2026, temporarily tightening free cash flow.
Working Capital Absorption Offsets Cash Gains
While operating cash flow was strong, higher working capital needs to support increased orders partially offset the benefit. Management noted that inventory and receivable build‑ups are a natural consequence of rapid growth and robust bookings but still weigh on near‑term cash generation.
Test Systems Still Sensitive to Volume and Mix
Despite the return to profit, Test Systems continues to face unfavorable mix and under‑absorption of fixed costs at current volumes. Executives stressed that more meaningful profitability will require higher production levels, making the segment particularly sensitive to program ramps.
Reliance on U.S. Army Radio Test Program
A key swing factor for Test Systems is the U.S. Army’s 4549T radio test program, where volume production has been delayed. The government shutdown pushed back the expected turn‑on, and while management is planning for a ramp in or shortly after the second quarter, timing remains a notable risk.
Acquisition and Transaction Costs Weigh on SG&A
Fourth‑quarter SG&A also included costs tied to the Buehler acquisition and other one‑time legal and accounting items. These transaction‑related expenses partially offset the benefit from lower litigation reserves but are not expected to recur at the same level.
Convertible Bond Structure and Potential Dilution
Diluted share count in the quarter reflected roughly 1.4 million implied shares from the remaining 5.5% convertible bonds, as the average share price exceeded the conversion level. The company’s new zero‑coupon convertible bonds would only become dilutive if the share price rises above $83.41, creating an equity overhang but also signaling upside if triggered.
2026 Outlook and Growth Trajectory
Astronics issued preliminary 2026 revenue guidance of $950 million to $990 million, implying about 12.5% growth at the midpoint and up to roughly 15% at the high end. Management expects first‑quarter sales between $220 million and $230 million, with a ramp that pushes second‑half quarterly revenue above $250 million and supports a long‑term goal of sustainable high‑teens operating margins.
Astronics’ earnings call painted a picture of a company emerging from a turnaround phase with record sales, stronger margins, and a fortified backlog pointing to continued growth. While higher leverage, tariff overhangs, and heavy 2026 investment create some near‑term risk, management’s confidence in demand, pricing power, and Test Systems recovery left investors with a broadly constructive outlook.

